Motonobu KAMEYAMA
Motonobu KAMEYAMA publishes mostly in Neurology, Surgery and Cellular and Molecular Neuroscience, on topics such as Cerebrovascular and Carotid Artery Diseases, Genetic Neurodegenerative Diseases and Neurological Disorders and Treatments.
- World rank
- #2,346,206 of 7,710,434 ranked researchers
- Rank in Japan
- #46,086 of 383,136
- Works
- 120
- Citations
- 2.8k
- Citations per work
- 23.6
What does Motonobu KAMEYAMA research?
Motonobu KAMEYAMA's work is mostly in Medicine (32%), Neuroscience (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6554.0%
- Health Sciences3831.9%
- Medicine3831.9%
- Life Sciences1714.1%
- Neuroscience1714.1%
- 1Neurology12% of their works
- 2Surgery8% of their works
- 3Cellular and Molecular Neuroscience8% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Neurology6% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Cerebrovascular and Carotid Artery Diseases
- Genetic Neurodegenerative Diseases
- Neurological Disorders and Treatments
- Neurological and metabolic disorders
- Acute Ischemic Stroke Management
- Parkinson's Disease Mechanisms and Treatments
- Neurological Disease Mechanisms and Treatments
- Advanced MRI Techniques and Applications
Which keywords describe Motonobu KAMEYAMA's research?
The keywords of their largest research topics: Mitochondrial Dysfunction, Oxidative Stress, Magnetic Resonance Imaging, Ischemic Stroke, Neuroprotection, Carotid Artery Stenosis, Endarterectomy and Huntington's Disease.
- Spectroscopy
- Cerebral Hypoperfusion
- Thrombolysis
- Endovascular Therapy
- Chorea
- Cerebrolysin
- Huntington's Disease
- Carotid Artery Stenosis
- Ischemic Stroke
- Oxidative Stress
- Mitochondrial Dysfunction
- Magnetic Resonance Imaging
- Neuroprotection
- Endarterectomy
- Protein Aggregation
- Citicoline
- Hyperglycemia
- Parkinson's Disease
- a-Synuclein
- Perfusion Imaging
- Vascular Cognitive Impairment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Mitochondrial Dysfunction243 topics
- Oxidative Stress193 topics
- Magnetic Resonance Imaging182 topics
- Ischemic Stroke142 topics
- Neuroprotection142 topics
- Carotid Artery Stenosis131 topic
- Endarterectomy131 topic
- Huntington's Disease101 topic
- Protein Aggregation101 topic
- Cerebrolysin81 topic
- Citicoline81 topic
- Chorea71 topic
- Hyperglycemia71 topic
- Endovascular Therapy61 topic
- Parkinson's Disease61 topic
- Thrombolysis61 topic
- a-Synuclein61 topic
- Cerebral Hypoperfusion51 topic
- Perfusion Imaging51 topic
- Spectroscopy51 topic
- Vascular Cognitive Impairment51 topic
Where does Motonobu KAMEYAMA work?
Motonobu KAMEYAMA's main affiliation in the publication record is Sumitomo Hospital, Japan.
How many publications and citations does Motonobu KAMEYAMA have?
OpenAlex counts 120 works and 2,830 citations for Motonobu KAMEYAMA, an h-index of 28, ranking #2,346,206 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Motonobu KAMEYAMA
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Motonobu KAMEYAMA. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.